Yoko Inai

2.8k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

Yoko Inai is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Yoko Inai has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Yoko Inai's work include Glycosylation and Glycoproteins Research (4 papers), Prion Diseases and Protein Misfolding (4 papers) and Trace Elements in Health (4 papers). Yoko Inai is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Prion Diseases and Protein Misfolding (4 papers) and Trace Elements in Health (4 papers). Yoko Inai collaborates with scholars based in Japan, United States and United Kingdom. Yoko Inai's co-authors include Jeffrey M. Isner, Hideki Iwaguro, Christoph Kalka, Takayuki Asahara, Donghui Chen, Haruchika Masuda, Marcy Silver, Tomono Takahashi, Morimitsu Nishikimi and Kozo Utsumi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Scientific Reports.

In The Last Decade

Yoko Inai

27 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1999 1.5k citations Takayuki Asahara, Tomono Takahashi et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Yoko Inai

Since Specialization

Citations

This map shows the geographic impact of Yoko Inai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Inai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Inai more than expected).

Fields of papers citing papers by Yoko Inai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Inai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Inai. The network helps show where Yoko Inai may publish in the future.

Co-authorship network of co-authors of Yoko Inai

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Inai. A scholar is included among the top collaborators of Yoko Inai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Inai. Yoko Inai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms 2024 ·Scientific Reports ·S Tabata, Yusuke Yamashita, Yoko Inai, Shuhei Morita, (unknown), (unknown), Kotaro Shide, Shino Manabe, (unknown), Kazuya Shimoda, Takashi Sonoki, Yoshito Ihara, Shinobu Tamura	0
2	Quantification of serum C-mannosyl tryptophan by novel assay to evaluate renal function and vascular complications in patients with type 2 diabetes 2021 ·Scientific Reports ·Shuhei Morita, Yoko Inai, (unknown), (unknown), Shino Manabe, Naoyuki Iwahashi, Kazuhiko Ino, Yukishige Ito, Takashi Akamizu, Yoshito Ihara	7
3	Role of C-mannosylation in the secretion of mindin 2020 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Yoko Inai, (unknown), (unknown), Michiko Tajiri, (unknown), Yoshinao Wada, Yoshito Ihara	6
4	Monomeric C-mannosyl tryptophan is a degradation product of autophagy in cultured cells 2020 ·Glycoconjugate Journal ·(unknown), Yoko Inai, Shino Manabe, Kazuchika Nishitsuji, Yukishige Ito, Yoshito Ihara	8
5	A novel assay for detection and quantification of C-mannosyl tryptophan in normal or diabetic mice 2019 ·Scientific Reports ·Sho Sakurai, Yoko Inai, (unknown), Shino Manabe, Yukishige Ito, Yoshito Ihara	10
6	C‑Mannosyl tryptophan increases in the plasma of patients with ovarian cancer 2019 ·Oncology Letters ·Naoyuki Iwahashi, Yoko Inai, (unknown), Sho Sakurai, Shino Manabe, Yukishige Ito, Kazuhiko Ino, Yoshito Ihara	4
7	In vivo role of aldehyde reductase 2012 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Motoko Takahashi, Satoshi Miyata, Junichi Fujii, Yoko Inai, Shigemitsu Ueyama, (unknown), Tomoyoshi Soga, Reiko Fujinawa, Chiaki Nishitani, Shigeru Ariki, Takeyuki Shimizu, Tomomi Abe, Yoshito Ihara, Morimitsu Nishikimi, Yasunori Kozutsumi, Naoyuki Taniguchi, Yoshio Kuroki	39
8	Protein C-Mannosylation and Its Prospective Functions in the Cell 2011 ·Trends in Glycoscience and Glycotechnology ·Yoshito Ihara, Yoko Inai, (unknown)	5
9	Alteration of integrin‐dependent adhesion and signaling in EMT‐like MDCK cells established through overexpression of calreticulin 2011 ·Journal of Cellular Biochemistry ·Yoshito Ihara, Yoko Inai, (unknown)	28
10	Calreticulin Inhibits Prion Protein PrP-(23–98) Aggregationin Vitro 2011 ·Bioscience Biotechnology and Biochemistry ·Noriyuki Shiraishi, Yoko Inai, Yoshiaki Hirano, Yoshito Ihara	4
11	Proteinase K-Resistant Aggregates of Recombinant Prion Protein PrP-(23-98) Are Toxic to Cultured Cells 2009 ·Protein and Peptide Letters ·Noriyuki Shiraishi, Yoko Inai, Yoshito Ihara	1
12	Enhanced Oxidative Stress by L-Ascorbic Acid within Cells Challenged by Hydrogen Peroxide 2005 ·Journal of Nutritional Science and Vitaminology ·Yoko Inai, Wenxiang Bi, Noriyuki Shiraishi, Morimitsu Nishikimi	6
13	Cytosolic Proteins as Principal Copper Buffer in an Early Response to Copper by Yeast Cells 2005 ·Journal of Clinical Biochemistry and Nutrition ·Wenxiang Bi, Yoko Inai, Noriyuki Shiraishi, Kazuhiro Maeta, Yoshifumi Takatsume, Yoshiharu Inoue, Morimitsu Nishikimi	1
14	The Whole Structure of the Human Nonfunctional L-Gulono-.GAMMA.-Lactone Oxidase Gene-the Gene Responsible for Scurvy-and the Evolution of Repetitive Sequences Thereon 2003 ·Journal of Nutritional Science and Vitaminology ·Yoko Inai, (unknown), Morimitsu Nishikimi	24
15	Increased degradation of oxidized proteins in yeast defective in 26S proteasome assembly 2002 ·Archives of Biochemistry and Biophysics ·Yoko Inai, Morimitsu Nishikimi	47
16	Ascorbate-Induced High-Affinity Binding of Copper to Cytosolic Proteins 2001 ·Biochemical and Biophysical Research Communications ·(unknown), Noriyuki Shiraishi, Yoko Inai, (unknown), Hideo Iwahashi, Morimitsu Nishikimi	8
17	Inactivation of wild-type BCR/ABL tyrosine kinase in hematopoietic cells by mild hyperthermia 2000 ·Leukemia ·(unknown), (unknown), Yoko Inai, (unknown), Lyuba Varticovski	3
18	Effects of a magnetic fields on the various functions of subcellular organelles and cells 2000 ·Pathophysiology ·Rumi Ishisaka, Tomoko Kanno, Yoko Inai, Hiroko Nakahara, Jitsuo Akiyama, Tamotsu Yoshioka, Kozo Utsumi	32
19	VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells breakdown → 1999 ·The EMBO Journal ·Takayuki Asahara, Tomono Takahashi, Haruchika Masuda, Christoph Kalka, Donghui Chen, Hideki Iwaguro, Yoko Inai, Marcy Silver, Jeffrey M. Isner	1483
20	Mitochondrial Dysfunction in the Senescence Accelerated Mouse (SAM) 1998 ·Free Radical Biology and Medicine ·Hiroko Nakahara, Tomoko Kanno, Yoko Inai, Kozo Utsumi, Midori Hiramatsu, Akitane Mori, Lester Packer	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact